Analyst Ratings for Xenon Pharmaceuticals (XENE)
XENE Rating Summary
XENE Price Target Summary
- Highest: $90.00 (Jefferies)
- Lowest: $46.00 (Deutsche Bank)
- Average: $72.07
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$72.07 (+93.3%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
Avg. $ Target:
$72.07 (+93.3%)
* Over Last 12-Mos
Rating Score: 9.6 / 10
Percentile Rank: 91%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/18/2026 | Deutsche Bank | David Hoang | Downgrade | Hold (Buy) |
46.00 (90.00) |
56.76 (37.28) |
-34.32% | Details |
| 2/24/2026 | Wolfe Research | Rudy Li | New Coverage | Outperform (N/A) |
60.00 (N/A) |
42.23 (37.28) |
-11.72% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
